Literature DB >> 8494719

Experimental pancreatic hyperplasia and neoplasia: effects of dietary and surgical manipulation.

P Watanapa1, R C Williamson.   

Abstract

Several studies carried out during the past two decades have investigated the effect of dietary and surgical manipulation on pancreatic growth and carcinogenesis. Diets high in trypsin inhibitor stimulate pancreatic growth and increase the formation of preneoplastic lesions and carcinomas in the rat pancreas. Cholecystokinin (CCK) is the key intermediary in this response, since both natural and synthetic trypsin inhibitors increase circulating levels of the hormone and CCK antagonists largely prevent these changes. Fatty acids enhance pancreatic carcinogenesis in both rats and hamsters, whereas protein appears to have a protective role in the rat, but to increase tumour yields in the hamster. Several surgical operations affect the pancreas. Pancreatobiliary diversion and partial gastrectomy stimulate pancreatic growth and enhance carcinogenesis, probably by means of increased CCK release. Complete duodenogastric reflux has similar effects on the pancreas but the gut peptide involved is gastrin. Although massive small bowel resection increases pancreatic growth, the marked reduction in caloric absorption probably explains its failure to enhance carcinogenesis. CCK and enteroglucagon might work in concert to modulate the tropic response of the pancreas to small bowel resection. In the pancreas, as in the large intestine, hyperplasia appears to precede and predispose to neoplasia.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8494719      PMCID: PMC1968422          DOI: 10.1038/bjc.1993.165

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  112 in total

1.  Are nitrite and N-nitroso compounds in gastric juice risk factors for carcinoma in the operated stomach?

Authors:  P Schlag; R Böckler; H Ulrich; M Peter; P Merkle; C Herfarth
Journal:  Lancet       Date:  1980-04-05       Impact factor: 79.321

2.  Evidence for an enterotropic hormone: compensatory hyperplasia in defunctioned bowel.

Authors:  R C Williamson; F L Bauer
Journal:  Br J Surg       Date:  1978-10       Impact factor: 6.939

3.  Carcinogenic effects of Di(2-hydroxypropyl)nitrosamine (DHPN) in male Wistar rats: promotion of pancreatic cancer by a raw soya flour diet.

Authors:  D A Levison; R G Morgan; J S Brimacombe; D Hopwood; G Coghill; K G Wormsley
Journal:  Scand J Gastroenterol       Date:  1979       Impact factor: 2.423

4.  The effects of long-term feeding of soya flour on the rat pancreas.

Authors:  E E McGuinness; R G Morgan; D A Levison; D L Frape; D Hopwood; K G Wormsley
Journal:  Scand J Gastroenterol       Date:  1980       Impact factor: 2.423

5.  Influence of repeated administration of cholecystokinin and secretin on the pancreas of the rat.

Authors:  U R Fölsch; K Winckler; K G Wormsley
Journal:  Scand J Gastroenterol       Date:  1978       Impact factor: 2.423

6.  Early lesions of pancreatic ductal carcinoma in the hamster model.

Authors:  P Pour; J Althoff; M Takahashi
Journal:  Am J Pathol       Date:  1977-08       Impact factor: 4.307

7.  Effect of chronic pentagastrin, cholecystokinin, and secretin on pancreas of rats.

Authors:  H Petersen; T Solomon; M I Grossman
Journal:  Am J Physiol       Date:  1978-03

8.  Ileal resection potentiates 1,2-dimethylhydrazine-induced colonic carcinogenesis.

Authors:  J E Oscarson; H F Veen; J S Ross; R A Malt
Journal:  Ann Surg       Date:  1979-04       Impact factor: 12.969

9.  Synthetic inhibitors of trypsin, plasmin, kallikrein, thrombin, C1r-, and C1 esterase.

Authors:  Y Tamura; M Hirado; K Okamura; Y Minato; S Fujii
Journal:  Biochim Biophys Acta       Date:  1977-10-13

10.  Growth of pancreas and gastrointestinal mucosa in antrectomized and gastrin-treated rats.

Authors:  A B Dembinski; L R Johnson
Journal:  Endocrinology       Date:  1979-09       Impact factor: 4.736

View more
  14 in total

1.  Resection of the gastric fundus in rats.

Authors:  R C Williamson; P Watanapa
Journal:  Gut       Date:  1994-01       Impact factor: 23.059

2.  Gene expression profiling defined pathways correlated with fibroblast cell proliferation induced by Opisthorchis viverrini excretory/secretory product.

Authors:  Chanitra Thuwajit; Peti Thuwajit; Kazuhiko Uchida; Daoyot Daorueang; Sasithorn Kaewkes; Sopit Wongkham; Masanao Miwa
Journal:  World J Gastroenterol       Date:  2006-06-14       Impact factor: 5.742

3.  A novel, clinically relevant animal model of metastatic pancreatic adenocarcinoma biology and therapy.

Authors:  B Wang; Q Shi; J L Abbruzzese; Q Xiong; X Le; K Xie
Journal:  Int J Pancreatol       Date:  2001

Review 4.  Mouse models of metastatic pancreatic adenocarcinoma.

Authors:  K Xie; B Wang; Q Shi; J L Abbruzzese; Q Xiong; X Le
Journal:  Int J Pancreatol       Date:  2001

Review 5.  On the role of cholecystokinin in pancreatic cancer.

Authors:  M K Herrington; T E Adrian
Journal:  Int J Pancreatol       Date:  1995-04

6.  Duodenogastric reflux and pancreatic growth.

Authors:  R C Williamson; P Watanapa
Journal:  Gut       Date:  1995-06       Impact factor: 23.059

7.  Pancreatic cancer after remote peptic ulcer surgery.

Authors:  M Tascilar; B P van Rees; P D J Sturm; G N J Tytgat; R H Hruban; S N Goodman; F M Giardiello; G J A Offerhaus; A C Tersmette
Journal:  J Clin Pathol       Date:  2002-05       Impact factor: 3.411

8.  Suppression of Ov-grn-1 encoding granulin of Opisthorchis viverrini inhibits proliferation of biliary epithelial cells.

Authors:  Atiroch Papatpremsiri; Michael J Smout; Alex Loukas; Paul J Brindley; Banchob Sripa; Thewarach Laha
Journal:  Exp Parasitol       Date:  2014-11-13       Impact factor: 2.011

9.  Risk of pancreatic cancer after cholecystectomy: a cohort study in Sweden.

Authors:  W Ye; J Lagergren; O Nyrén; A Ekbom
Journal:  Gut       Date:  2001-11       Impact factor: 23.059

10.  Synchronous double cancers of the remnant stomach and pancreas: report of a case.

Authors:  T Miyaguni; Y Muto; T Kusano; M Yamada; M Matsumoto; M Shiraishi
Journal:  Surg Today       Date:  1995       Impact factor: 2.549

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.